Dr. Igor A. Astsaturov, MD

Dr. Astsaturov practices at Fox Chase Cancer Center in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Astsaturov's NPI, 1235314204, was assigned on January 8, 2008. Dr. Astsaturov holds Pennsylvania license MD427094.

Dr. Astsaturov's primary practice is Fox Chase Cancer Center, at 333 Cottman Avenue, Philadelphia, PA 19111.

Dr. Astsaturov's primary practice is Fox Chase Cancer Center in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Astsaturov is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Astsaturov practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Astsaturov's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Astsaturov is licensed in Pennsylvania.

CMS data shows 188 Medicare services from Dr. Astsaturov across 2 procedure codes in 2024, all of them office visits, for 63 Medicare patients. Medicare paid $16,853 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Dr. Astsaturov in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Astsaturov's median patient age at 70, with 43% women.

In 2024, Dr. Astsaturov wrote 374 Medicare Part D claims for 49 patients. 85% of them were for generic drugs. CMS names the drug for 213 of them, across 9 drugs with 11 or more claims each, at $569,430 in total drug cost. In 2023, CMS named 254 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Astsaturov for performance year 2024, reported as part of a group. Dr. Astsaturov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Dr. Astsaturov from 5 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 51% of the total. Caris MPI, Inc. paid the most, $990.